Dammit 1mm microadenoma

m_ob

New Member
I had undergone an MRI a few months ago and was told by my endocrinologist that it came back unremarkable, meaning fine, no masses nothing. I asked then that it would be sent to my primary physiscian at the hospital in Des Moines. It took them a while but they got it there and the first thing my physiscian noticed was a small 1millimeter microadenoma. Of course the endocrinologist would not inform me of this. God forbid it give me reason to ask questions. I'm asking this to clarify the signifignance of this finding. Does a one millimeter microadenoma even matter?
 
Do these levels even look hypopituitary?
TSH 1.90 (.35-5.50)
LH 2.2 (1.5-9.3) L
FSH 2.5(1.4-18.1) L
Prolactin 6.3 (2.6-18.1)
IGF-1- 243 range (257-601)
ACTH 4:00 p.m 23 (10-60) a.m range

I don't know. I do know they look pretty darn close to my numbers, and no doctor has ever told me I am hypopituitary. (Minus the ACTH test)
 
I don't know. I do know they look pretty darn close to my numbers, and no doctor has ever told me I am hypopituitary. (Minus the ACTH test)

Maybe I am not eating enough, Reverse t3 was very high. Sometimes I am only getting 1,500 calories a day due to school and work.
 
Maybe I am not eating enough, Reverse t3 was very high. Sometimes I am only getting 1,500 calories a day due to school and work.

Dude. GOD DAMNIT. Doesn't it always come back to this?

I really, really, really, really (really) think that you need to start eating more. If you have a hard time doing it start eating a lot of calorically dense foods i.e. peanut butter, pasta, olive oil, etc.

Hell man, put two tblspoons of olive oil on your salad at dinner, that's like 500 calories right there.

Even if you do legitimately have eurothyroid sick syndrome, which would be characterized by your high rt3, if you fix the underlying problem i.e. your starvation, the thyroid will normalize.

Why haven't you started eating more?
 
Dude. GOD DAMNIT. Doesn't it always come back to this?

I really, really, really, really (really) think that you need to start eating more. If you have a hard time doing it start eating a lot of calorically dense foods i.e. peanut butter, pasta, olive oil, etc.

Hell man, put two tblspoons of olive oil on your salad at dinner, that's like 500 calories right there.

Even if you do legitimately have eurothyroid sick syndrome, which would be characterized by your high rt3, if you fix the underlying problem i.e. your starvation, the thyroid will normalize.

Why haven't you started eating more?

Over summer I was doing a good job of putting in, come school time all I'm doing is going between classes and school lunch is not calorie dense at all and with wrestling I'm only allowed well basically jack shit. Maybe I need to stop wrestling.
 
Bro seriously eat all you want!. eat as much as you can like I said stuff in a huge breakfast and lunch and when work comes around just wait until you get home and munch on alot of shit. I eat like a mad man when I get home from school because I don't eat lunch there. Disipline and organize your self and you can get almost anything done bro. Its not even a matter of looking at labels your 16 eat whatever you want just try not to eat horribly lol.
 
Over summer I was doing a good job of putting in, come school time all I'm doing is going between classes and school lunch is not calorie dense at all and with wrestling I'm only allowed well basically jack shit. Maybe I need to stop wrestling.

bro id say stop wrestling and figure shit out. The extra time is freaking amazing. Once I quit sport I got all on eating well/better excersizing at the right time. If you can only eat jack shit man wrestling isn't helping you. And how the heck do you have enough energy for wrestling any way. I swear you T is still under the 300s. If you feel you can wrestle though and keep up with everything else GO FOR IT. But school, wrestling, and job man thats a whole lot. I assume your stress level is high and that sounds like you don't have much time to just chill and get your head clear.
 
Over summer I was doing a good job of putting in, come school time all I'm doing is going between classes and school lunch is not calorie dense at all and with wrestling I'm only allowed well basically jack shit. Maybe I need to stop wrestling.
m_ob, trying to recover from health issues like you have whilst competiting in any sport that has weight resrictions is a really, really bad idea. In fact trying to be a competitive athlete when not in good health is asking for trouble, as is having an obsessive personality / eating disorder which you will have to ask yourself if you have.

I am guessing this (under eating and overtraining) is much of the problem that is holding you back... if it is then you need to put your athletic ambitions on hold and get better first so you can come back in the future and kick a$$!

Good luck!
 
I had undergone an MRI a few months ago and was told by my endocrinologist that it came back unremarkable, meaning fine, no masses nothing. I asked then that it would be sent to my primary physiscian at the hospital in Des Moines. It took them a while but they got it there and the first thing my physiscian noticed was a small 1millimeter microadenoma. Of course the endocrinologist would not inform me of this. God forbid it give me reason to ask questions. I'm asking this to clarify the signifignance of this finding. Does a one millimeter microadenoma even matter?

Is your physician a radiologist, specializing in MRI? Further, your use of the term hypopituitary is misleading, be more specific. From recollection, your T was low, making you hypogonadal

Finally, as per my PM. a good topic for the forum would be on Endocrine Incidentalomas. This will help many others and release you from your apparent anxiety. I will help you (co-author) a post on this subject of personal importance to you!
 
Is your physician a radiologist, specializing in MRI? Further, your use of the term hypopituitary is misleading, be more specific. From recollection, your T was low, making you hypogonadal

Finally, as per my PM. a good topic for the forum would be on Endocrine Incidentalomas. This will help many others and release you from your apparent anxiety. I will help you (co-author) a post on this subject of personal importance to you!

I like the way you think. Do work to further understanding. The only thing I struggle with is wondering if recovery is not possible and I have some sort of pituitary problem that causes malproduction of hormones.
 
Endocrine incidentalomas

Endocrine incidentalomas are very common in the practice of every physician, mostly primary care and family physicians. Incidentalomas are discovered in the thyroid, pituitary and adrenal glands during imaging studies performed for non-endocrine reasons. Thyroid incidentalomas are very common, with a prevalence close to 50% on imaging studies. Thyroid-stimulating hormone (TSH) is the first test to obtain if it's not low the next step is a biopsy of any nodule above 1 cm and/or weird ultrasound characteristics such as bumps or something out of the ordinary. Adrenal incidentalomas are not very common at all . All adrenal nodules above 4 cm should be checked out . Regardless of the size, a workup for blood tests should always be done. Only very sensitive patients should be screened for primary hyperaldosteronism.

Pituitary incidentalomas happen a lot , with a prevalence of 10-20%. All patients with pituitary masses should have a workup for hormonal hypersecretion meaning above normal secretion. Only patients with macroadenomas will have additional screening for hypopituitarism and visual field defects. All hyperfunctioning adenomas are resected except prolactinomas which are treated medically. The same if a macroadenoma is causing hypopituitarism or visual deficit, surgery should also be considered

My microadenoma does not clinically need screening for deficiencies, only macroadenomas.
 
Re: Endocrine incidentalomas

Endocrine incidentalomas are very common in the practice of every physician, mostly primary care and family physicians. Incidentalomas are discovered in the thyroid, pituitary and adrenal glands during imaging studies performed for non-endocrine reasons. Thyroid incidentalomas are very common, with a prevalence close to 50% on imaging studies. Thyroid-stimulating hormone (TSH) is the first test to obtain if it's not low the next step is a biopsy of any nodule above 1 cm and/or weird ultrasound characteristics such as bumps or something out of the ordinary. Adrenal incidentalomas are not very common at all . All adrenal nodules above 4 cm should be checked out . Regardless of the size, a workup for blood tests should always be done. Only very sensitive patients should be screened for primary hyperaldosteronism.

Pituitary incidentalomas happen a lot , with a prevalence of 10-20%. All patients with pituitary masses should have a workup for hormonal hypersecretion meaning above normal secretion. Only patients with macroadenomas will have additional screening for hypopituitarism and visual field defects. All hyperfunctioning adenomas are resected except prolactinomas which are treated medically. The same if a macroadenoma is causing hypopituitarism or visual deficit, surgery should also be considered

My microadenoma does not clinically need screening for deficiencies, only macroadenomas.

Whew!!! That is damn good and quick. This is an important topic. I have known people to undergo unnecessary surgery!
 
Re: Endocrine incidentalomas

Whew!!! That is damn good and quick. This is an important topic. I have known people to undergo unnecessary surgery!

Surgery that could very well end their hormone production for good if not their life.
 
Last edited:
The size of a microadenoma is only concerning if it results in compression of the surrounding structures. Typically the Optic Chiasm and your initial complaint will be vision changes. There is an arbitrary cutoff with anything less than 10mm being "micro" and greater than 10mm being called 'macro' -adenomas.

However, a FUNCTIONING microadenoma can have significant effects. Functioning means that it is producing hormone outside of normal regulatory channels. ie the gas pedal is stuck and it is pouring out whatever hormone it is designed to make. It is most often Prolactin, however, can be LH or FSH as well. The 'size' of these lesions are typically meaningless, because small functioning lesions can produce enough hormone to cause problems, whereas often times very LARGE adeonomas produce little or nothing at all. One caveat to this is if the size of the non-functioning adenoma was so large as to severely compress the other 'normal' pituitary to the degree that it had difficulty functioning. However, this is extremely rare, and I have seen 'normal' pituitary output from paper thin compressed pituitary glands.

The determination is relatively simple. Simply check hormone levels. Check Prolactin, FSH, and LH. If they are normal, then it is a non-issue at this time and would not be related to whatever you have going on.

In reality, a 1mm lesion might very well simply BE artifact. The resolution of MR is only about .5 to 1mm, so actually 'calling' something as being there at that size is more of a 'thought' than a real issue.
 
Cascade Effect Is A Problem in Endocrinology.

Thank you for bringing up the very important and relevant topic of Endocrine Incidentalomas.

Cascade Effect Is A Problem in Endocrinology.

Mold & Stein apparently coined the term cascade effect, in reference to medical technology, in a 1986 article in the New England Journal of Medicine. Cascade effect refers to a process that proceeds in stepwise fashion from an initiating event to a seemingly inevitable conclusion. The chain of events in which an initiating factor (an unnecessary test or procedure, an unexpected result, or patient or physician anxiety) occurs with increasing momentum followed by a series of events that result in ill-advised tests or treatments that may cause avoidable adverse effects, increased risks and/or morbidity. The further events progress, the more difficult they are to stop. Unfortunately, their use in routine care sometimes proves futile or even harmful. The adverse effects and consequences of new technology are often unanticipated.

Examples include discovery of endocrine incidentalomas on head and body scans; irrelevant abnormalities on spinal imaging; tampering with random fluctuations in clinical measures; and unwanted aggressive care at the end of life. Published medical literature states, "In patients with an incidental asymptomatic pituitary microadenoma, a single PRL test may be the most cost-effective management strategy" that determines further medical care.

Health professionals and laypersons alike tend to equate new medical technology with better-quality health care, assuming that newer is better. Much of the scientific literature on diffusion of innovations focuses on the anticipated beneficial effects of new technology and methods to ensure its rapid adoption. Technologic advancement in radiologic imaging has contributed to the development of an era during which preclinical or subclinical disease is detected in patients with incidentally discovered pituitary masses. However, many new medical technologies are introduced and disseminated with only modest evaluation of efficacy, optimal indications, or impact on practice.

Subjecting patients to unnecessary testing and treatment is associated with risk. In addition to its initial cost, testing may result in further expense and harm as false-positive results are pursued, producing the "cascade effect" described by Mold and Stein. The extensive evaluations performed for some patients with incidentally discovered masses may reflect the unwillingness of many physicians to accept uncertainty, even in the case of an extremely unlikely diagnosis.

This unwillingness may be driven, in part, by fear of potential malpractice liability, the failure to appreciate the influence of prevalence data on the interpretation of diagnostic testing, or other factors. The major justification for further evaluation of these patients is not so much to avoid morbidity and mortality for the rare patient who truly is at increased risk but to reassure patients in whom further testing is negative and the physician.

Physicians must take care not to create inappropriate anxiety in patients by overemphasizing the importance of an incidental finding unless it is associated with a realistic clinical risk. The initiating factor is often physician anxiety, which may result, for example, in a diagnostic test, an unexpected result, and a chain of subsequent events that are ultimately to the patient's disadvantage. Physicians who are anxious about a patient's problem may be tempted to do nearly anything in order to reduce their own anxiety.

The first step typically appears to be a benign action, such as ordering a diagnostic test; however, the discovery of an unexpected abnormality leads to progressively riskier and costlier interventions that seem simultaneously unnecessary and unavoidable. Similarly, as physicians try to explain each new ambiguous result, they become ensnared by their own actions.

Mold &Stein pointed out that in clinical care, cascade effects could be triggered inappropriately by incomplete data gathering; over interpretation of an abnormal lab result; underestimation of the risks of a test or treatment; underestimation of the possibility of false-positive results; and intolerance of ambiguity by the physician. Because of the near inevitability of certain cascades once they are initiated, the best chance of preventing unnecessary adverse consequences may be to prevent the triggering event.

Common Triggers For The Cascade Effect.

A wide variety of likely triggers have been identified, relating to both psychological and cognitive factors, as well as cultural attitudes and perverse incentives Common triggers include failing to understand the likelihood of false-positive results; errors in data interpretation; overestimating benefits or underestimating risks; and low tolerance of ambiguity. Excess capacity and perverse financial incentives may contribute to cascade effects as well.

Shotgun Testing.

A nearly ubiquitous feature of modern medical practice is the panel of laboratory tests ordered as a cluster.

Underestimating the Likelihood of False-Positive Results.

For many biochemical tests of blood or urine, the normal range is simply defined as two standard deviations from the mean of a healthy population. By definition, therefore, about 5% of results on each test from normal

Defensive Medicine.

Physicians sometimes request unnecessary tests or treatments in order to avoid medicolegal liability for a missed diagnosis or treatment opportunity. However, poorly thought-out testing may sometimes lead to more patient harm than good, paradoxically increasing medicolegal risks. Formal decision analysis produces the somewhat surprising result that defensive medicine necessarily reduces the overall quality of patient care. This finding contradicts arguments that defensive testing may further the interests of both doctor and patient. The reason is related to the problem of false-positive and false-negative tests. Decision analysis allows calculation of an optimal testing threshold: a pretest likelihood of disease that makes testing the preferred strategy over simply treating without a test or not treating at all. This threshold depends in part on the true- and false-positive rates of the test, and the consequences of those errors.

Inappropriate Screening.

If a physician widens the range of possibilities over which he or she prefers testing in order to reduce liability, then some patients who would be better left untreated will instead be tested and treated if the test is positive.

Errors in Data Interpretation.

Similarly, some patients who should be treated will instead be tested, and treatment withheld if the test is negative. The argument is theoretical, and actual practice may rarely conform to the optimal strategy in any event, for a number of reasons. Nonetheless, the analysis suggests that defensive medicine is not merely a problem of increased cost, but also one of reduced quality-of-care .

Consequences Of Cascade Phenomena.

Perhaps the most worrisome potential consequences of cascade phenomena are iatrogenic illness, morbidity, and mortality. Starfield has summarized some of the evidence for adverse effects that occur because of iatrogenic injuries not associated with recognizable error. These include some 12,000 deaths a year from unnecessary surgery, 80,000 deaths per year from infections in hospitals, and 106,000 deaths per year from non-error-related adverse effects of medications. It is impossible to determine what fraction of these are related to cascade effects, but we may speculate that it is a substantial fraction.

Data such as those from randomized trials of more aggressive or conservative management for acute coronary syndromes suggest that the aggressive strategy does not improve mortality, and its complications may increase mortality in some settings. Expert panels have judged that a substantial fraction of back surgery in the United States is unnecessary and exposes patients to unnecessary complications and even mortality.

The abundance of technology and specialists in the United States, compared with most other developed countries, has not assured better public health: The United States ranks tenth or below for indicators such as low birth weight percentage, neonatal mortality, years of potential life lost, and life expectancy at age 1, age 15, and age 40.

A less obvious consequence of cascade phenomena may be labeling effects for patients who have no disease. This problem has been demonstrated, for example, among children with benign heart murmurs, who experience greater restriction of physical activity than children without cardiac murmurs, despite having normal hearts. Anecdotal experience suggests that many patients who have spinal MRI tests attribute great importance to findings of bulging discs or other degenerative changes, despite evidence that these are as common in asymptomatic patients as among those with back pain.

There is some evidence to suggest that simply attaching a diagnosis to patients who were previously unaware of having high blood pressure may result in greater work absenteeism, regardless of whether therapy is begun. Thus, labeling effects may be associated with unnecessary disability.

Unnecessary costs are an obvious consequence of cascade effects. The follow-up testing required for unexpected abnormalities, ongoing monitoring, and management of complications for unnecessary procedures are all examples of cost without benefit in the health care system. One of the mechanisms by which treatment complications may occur is tampering with stable conditions. Tampering occurs when adjustments are made to correct deviations in a system that reflect random variation rather than systematic change. Intervening in response to random variations actually causes a system to become less stable and increases the likelihood of unnecessary treatment and adverse events. Modern physicians are flooded with measurements as we monitor a host of physiologic phenomena.

Preventing cascade effects may require better education of physicians and patients; research on the natural history of mild diagnostic abnormalities; achieving optimal capacity in health care systems; and awareness that more is not the same as better.
 

Attachments

Last edited:
Re: Cascade Effect Is A Problem in Endocrinology.

Thank you for bringing up the very important and relevant topic of Endocrine Incidentalomas.

Cascade Effect Is A Problem in Endocrinology.

Mold & Stein apparently coined the term cascade effect, in reference to medical technology, in a 1986 article in the New England Journal of Medicine. Cascade effect refers to a process that proceeds in stepwise fashion from an initiating event to a seemingly inevitable conclusion. The chain of events in which an initiating factor (an unnecessary test or procedure, an unexpected result, or patient or physician anxiety) occurs with increasing momentum followed by a series of events that result in ill-advised tests or treatments that may cause avoidable adverse effects, increased risks and/or morbidity. The further events progress, the more difficult they are to stop. Unfortunately, their use in routine care sometimes proves futile or even harmful. The adverse effects and consequences of new technology are often unanticipated.

Examples include discovery of endocrine incidentalomas on head and body scans; irrelevant abnormalities on spinal imaging; tampering with random fluctuations in clinical measures; and unwanted aggressive care at the end of life. Published medical literature states, "n patients with an incidental asymptomatic pituitary microadenoma, a single PRL test may be the most cost-effective management strategy" that determines further medical care.

Health professionals and laypersons alike tend to equate new medical technology with better-quality health care, assuming that newer is better. Much of the scientific literature on diffusion of innovations focuses on the anticipated beneficial effects of new technology and methods to ensure its rapid adoption. Technologic advancement in radiologic imaging has contributed to the development of an era during which preclinical or subclinical disease is detected in patients with incidentally discovered pituitary masses. However, many new medical technologies are introduced and disseminated with only modest evaluation of efficacy, optimal indications, or impact on practice.

Subjecting patients to unnecessary testing and treatment is associated with risk. In addition to its initial cost, testing may result in further expense and harm as false-positive results are pursued, producing the "cascade effect" described by Mold and Stein. The extensive evaluations performed for some patients with incidentally discovered masses may reflect the unwillingness of many physicians to accept uncertainty, even in the case of an extremely unlikely diagnosis.

This unwillingness may be driven, in part, by fear of potential malpractice liability, the failure to appreciate the influence of prevalence data on the interpretation of diagnostic testing, or other factors. The major justification for further evaluation of these patients is not so much to avoid morbidity and mortality for the rare patient who truly is at increased risk but to reassure patients in whom further testing is negative and the physician.

Physicians must take care not to create inappropriate anxiety in patients by overemphasizing the importance of an incidental finding unless it is associated with a realistic clinical risk. The initiating factor is often physician anxiety, which may result, for example, in a diagnostic test, an unexpected result, and a chain of subsequent events that are ultimately to the patient?s disadvantage. Physicians who are anxious about a patient?s problem may be tempted to do nearly anything in order to reduce their own anxiety.

The first step typically appears to be a benign action, such as ordering a diagnostic test; however, the discovery of an unexpected abnormality leads to progressively riskier and costlier interventions that seem simultaneously unnecessary and unavoidable. Similarly, as physicians try to explain each new ambiguous result, they become ensnared by their own actions.

Mold &Stein pointed out that in clinical care, cascade effects could be triggered inappropriately by incomplete data gathering; over interpretation of an abnormal lab result; underestimation of the risks of a test or treatment; underestimation of the possibility of false-positive results; and intolerance of ambiguity by the physician. Because of the near inevitability of certain cascades once they are initiated, the best chance of preventing unnecessary adverse consequences may be to prevent the triggering event.

Common Triggers For The Cascade Effect.

A wide variety of likely triggers have been identified, relating to both psychological and cognitive factors, as well as cultural attitudes and perverse incentives Common triggers include failing to understand the likelihood of false-positive results; errors in data interpretation; overestimating benefits or underestimating risks; and low tolerance of ambiguity. Excess capacity and perverse financial incentives may contribute to cascade effects as well.

Shotgun Testing.

A nearly ubiquitous feature of modern medical practice is the panel of laboratory tests ordered as a cluster.

Underestimating the Likelihood of False-Positive Results.

For many biochemical tests of blood or urine, the normal range is simply defined as two standard deviations from the mean of a healthy population. By definition, therefore, about 5% of results on each test from normal

Defensive Medicine.

Physicians sometimes request unnecessary tests or treatments in order to avoid medicolegal liability for a missed diagnosis or treatment opportunity. However, poorly thought-out testing may sometimes lead to more patient harm than good, paradoxically increasing medicolegal risks. Formal decision analysis produces the somewhat surprising result that defensive medicine necessarily reduces the overall quality of patient care. This finding contradicts arguments that defensive testing may further the interests of both doctor and patient. The reason is related to the problem of false-positive and false-negative tests. Decision analysis allows calculation of an optimal testing threshold: a pretest likelihood of disease that makes testing the preferred strategy over simply treating without a test or not treating at all. This threshold depends in part on the true- and false-positive rates of the test, and the consequences of those errors.

Inappropriate Screening.

If a physician widens the range of possibilities over which he or she prefers testing in order to reduce liability, then some patients who would be better left untreated will instead be tested and treated if the test is positive.

Errors in Data Interpretation.

Similarly, some patients who should be treated will instead be tested, and treatment withheld if the test is negative. The argument is theoretical, and actual practice may rarely conform to the optimal strategy in any event, for a number of reasons. Nonetheless, the analysis suggests that defensive medicine is not merely a problem of increased cost, but also one of reduced quality-of-care .

Consequences Of Cascade Phenomena.

Perhaps the most worrisome potential consequences of cascade phenomena are iatrogenic illness, morbidity, and mortality. Starfield has summarized some of the evidence for adverse effects that occur because of iatrogenic injuries not associated with recognizable error. These include some 12,000 deaths a year from unnecessary surgery, 80,000 deaths per year from infections in hospitals, and 106,000 deaths per year from non?error-related adverse effects of medications. It is impossible to determine what fraction of these are related to cascade effects, but we may speculate that it is a substantial fraction.

Data such as those from randomized trials of more aggressive or conservative management for acute coronary syndromes suggest that the aggressive strategy does not improve mortality, and its complications may increase mortality in some settings. Expert panels have judged that a substantial fraction of back surgery in the United States is unnecessary and exposes patients to unnecessary complications and even mortality.

The abundance of technology and specialists in the United States, compared with most other developed countries, has not assured better public health: The United States ranks tenth or below for indicators such as low birth weight percentage, neonatal mortality, years of potential life lost, and life expectancy at age 1, age 15, and age 40.

A less obvious consequence of cascade phenomena may be labeling effects for patients who have no disease. This problem has been demonstrated, for example, among children with benign heart murmurs, who experience greater restriction of physical activity than children without cardiac murmurs, despite having normal hearts. Anecdotal experience suggests that many patients who have spinal MRI tests attribute great importance to findings of bulging discs or other degenerative changes, despite evidence that these are as common in asymptomatic patients as among those with back pain.

There is some evidence to suggest that simply attaching a diagnosis to patients who were previously unaware of having high blood pressure may result in greater work absenteeism, regardless of whether therapy is begun. Thus, labeling effects may be associated with unnecessary disability.

Unnecessary costs are an obvious consequence of cascade effects. The follow-up testing required for unexpected abnormalities, ongoing monitoring, and management of complications for unnecessary procedures are all examples of cost without benefit in the health care system. One of the mechanisms by which treatment complications may occur is tampering with stable conditions. Tampering occurs when adjustments are made to correct deviations in a system that reflect random variation rather than systematic change. Intervening in response to random variations actually causes a system to become less stable and increases the likelihood of unnecessary treatment and adverse events. Modern physicians are flooded with measurements as we monitor a host of physiologic phenomena.

Preventing cascade effects may require better education of physicians and patients; research on the natural history of mild diagnostic abnormalities; achieving optimal capacity in health care systems; and awareness that more is not the same as better.


Well needed and well composed.
 
Last edited by a moderator:
Nieman LK. Approach to the Patient with an Adrenal Incidentaloma. J Clin Endocrinol Metab 2010;95(9):4106-13.

Unsuspected adrenal masses, or incidentalomas, are increasingly found with the widespread use of thoracic and abdominal imaging. These masses may be hormonally active or nonfunctional and malignant or benign. Clinicians must determine the nature of the mass to decide what treatment, if any, is needed. Measurement of precontrast Hounsfield units (HU) and contrast washout on computed tomography scan provide useful diagnostic information. All patients should undergo biochemical testing for pheochromocytoma, either with plasma or urinary catecholamine measurements. This is particularly important before surgical resection, which is routinely recommended for masses larger than 4 cm in diameter without a clear-cut diagnosis and for others with hormonal secretion or ominous imaging characteristics. Hypertensive patients should undergo biochemical testing for hyperaldosteronism. Patients with features consistent with Cushing's syndrome, such as glucose intolerance, weight gain, and unexplained osteopenia, should be evaluated for cortisol excess. Here, the dexamethasone suppression test and late-night salivary cortisol may be preferred over measurement of urine cortisol. The ability of surgical resection to reverse features of mild hypercortisolism is not well established. For masses that appear to be benign (<10 HU; washout, >50%), small (<3 cm), and completely nonfunctioning, imaging and biochemical reevaluation (pheochromocytoma and hypercortisolism only) at 1-2 yr (or more) is appropriate. For more indeterminate lesions, repeat evaluation for growth after 3-12 months is useful, with subsequent testing intervals based on the rate of growth.
 

Attachments

Back
Top